Search results
ASCO 2024: Key Takeaways on Therapeutic Advancements in CML
Medscape· 6 days agoJorge E. Cortes, MD, highlights results for asciminib as a first-line therapy, and offers insights...
2024 American Oncology Annual Meeting Concludes in Chicago, CANCER CASES SURGE IN WESTERN COUNTRIES,...
The Belmond Independent· 5 days agoThe 2024 edition of the American Society of Clinical Oncology (ASCO) Congress highlighted a...
ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy
BioPharma-Reporter· 4 days agoThe US firm AffyImmune Therapeutics discusses how its donor cell-derived candidate could address...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 5 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
Motley Fool via Yahoo Finance· 5 days agoIn that vein, at the 2024 meeting of the American Society of Clinical Oncology (ASCO) on May 31,...
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing...
Benzinga· 6 days agoIn addition, the first instance of brain tumor activity was recorded in Cohort 4, with a 28.6% reduction...
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 2 days agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
NHS genomics testing will be vital in supporting personalised cancer trials
Clinical Trials Arena via Yahoo Finance· 1 day agoRecent data presented at the American Society of Clinical Oncology (ASCO) Meeting 2024 showed the...
One Patient Changed This Onc's View of Hope. Here's How.
Medscape· 4 days agoOne Patient Changed This Oncologist's View of Hope. Following a stem cell transplant for leukemia,...
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Medscape· 4 days agoThe new findings help settle a long-standing debate and will impact disease management, but local...